Integrity Advisory, LLC Vertex Pharmaceuticals Inc Transaction History
Integrity Advisory, LLC
- $103 Million
- Q4 2022
A detailed history of Integrity Advisory, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Integrity Advisory, LLC holds 1,512 shares of VRTX stock, worth $600,672. This represents 0.42% of its overall portfolio holdings.
Number of Shares
1,512
Previous 2,297
34.18%
Holding current value
$600,672
Previous $665,000
34.44%
% of portfolio
0.42%
Previous 0.62%
Shares
3 transactions
Others Institutions Holding VRTX
# of Institutions
1,724Shares Held
221MCall Options Held
1.58MPut Options Held
1.36M-
Capital World Investors Los Angeles, CA26.8MShares$10.7 Billion1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.2MShares$9.2 Billion0.2% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$8.47 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.8MShares$4.69 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA9MShares$3.58 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $102B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...